What is the relationship between acute kidney injury (AKI) and seizures?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Acute Kidney Injury and Seizures: A Bidirectional Relationship

Acute kidney injury (AKI) and seizures have a clinically significant bidirectional relationship—seizures can cause AKI through multiple mechanisms, and AKI can precipitate seizures through uremic encephalopathy and electrolyte disturbances.

Seizures as a Cause of AKI

Primary Mechanisms

Generalized tonic-clonic seizures (GTCS) can directly trigger AKI through several pathophysiologic pathways 1:

  • Acute hyperuricemia: Seizure-induced muscle breakdown releases massive amounts of uric acid, causing urate nephropathy. In one prospective series, median serum uric acid peaked at 346.0 µmol/L immediately post-seizure before declining to 178.0 µmol/L by day 3, with AKI occurring in 31% of patients 1.

  • Hypoxia-induced tubular injury: Convulsions cause systemic hypoxia, which was documented in 67.9% of febrile seizure patients. This hypoxic state directly damages renal tubular cells, evidenced by elevated urinary kidney injury markers (NGAL, NAG, L-FABP) that were significantly higher in seizure patients compared to controls 2.

  • ALPE syndrome: Acute renal failure with severe loin pain and patchy renal ischemia can occur post-seizure, characterized by patchy renal vasoconstriction visible on contrast-enhanced CT and diffusion-weighted MRI 3.

Clinical Implications

Monitor serum uric acid and creatinine immediately following any GTCS episode, particularly if seizure duration exceeds 5 minutes 1. The kinetics show peak injury markers at day 0-1 with gradual normalization by day 3, but this window represents critical risk for AKI development.

AKI as a Cause of Seizures

Kidney-Specific Etiologies

Patients with kidney disease develop seizures through distinct mechanisms 4:

  • Uremic encephalopathy: Accumulation of uremic toxins directly irritates cerebral cortex neurons
  • Dialysis disequilibrium syndrome: Rapid osmotic shifts during dialysis
  • Severe hyponatremia: Particularly in the context of fluid overload or inappropriate fluid management
  • Drug/metabolite accumulation: Renally-cleared medications and their metabolites accumulate in AKI, lowering seizure threshold

Critical Management Consideration

The most dangerous pitfall is drug accumulation in AKI patients—antiepileptic drugs must be dose-adjusted based on renal clearance, and nephrotoxic medications should be reviewed immediately 5. The KDIGO guidelines emphasize that drug stewardship is paramount, requiring assessment of the dynamic impact of AKI on drug pharmacokinetics/pharmacodynamics 5.

Practical Clinical Algorithm

When Seizure Occurs First:

  1. Immediate labs: Serum uric acid, creatinine, CK, lactate, blood gas
  2. Day 1-3 monitoring: Serial creatinine and uric acid to capture peak injury
  3. Urine studies: Dipstick for blood/protein, microscopy for crystals and tubular cells
  4. Imaging if AKI develops: Consider DWI-MRI over CT for detecting patchy ischemia without contrast risk 3

When AKI Occurs First:

  1. Medication reconciliation: Review all renally-cleared drugs and adjust doses
  2. Electrolyte correction: Aggressive management of hyponatremia, hypocalcemia, hypomagnesemia
  3. Seizure prophylaxis consideration: In severe uremia (BUN >100 mg/dL) or rapid electrolyte shifts
  4. Avoid nephrotoxic antiepileptics: If seizures occur, select agents with hepatic metabolism when possible

Key Caveats

The evidence shows that seizure-induced AKI is typically mild and reversible within 12 days 1, 3, but this assumes prompt recognition and supportive care. The subclinical renal damage detected by urinary biomarkers suggests that even "mild" seizures may cause kidney injury not captured by creatinine alone 2.

Do not withhold necessary treatments due to AKI concerns—the KDIGO guidelines explicitly state that potentially nephrotoxic agents should not be withheld in life-threatening conditions 5. However, kidney function must be monitored closely, and drug stewardship with clinical pharmacist involvement is essential 5.

The long-term implications are concerning: AKI significantly increases the risk of cognitive impairment (OR = 1.87) 6, creating a potential vicious cycle where AKI leads to neurologic complications that may include seizures, which then worsen kidney function.

References

4
Research

Seizures in patients with kidney diseases: a neglected problem?

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2023

Related Questions

In a patient with pending neurology referral who is experiencing focal seizure-like symptoms and has recurrent acute kidney injury, how should these events be evaluated while awaiting EEG confirmation?
How can I differentiate acute kidney injury (AKI) from chronic kidney disease (CKD) and what are the appropriate management strategies for each?
Which antiepileptic drugs are appropriate for patients with chronic kidney disease (CKD) and how should their doses be adjusted according to renal function?
What anti-epileptic (seizure) medications have a lower risk of nephrotoxicity (kidney damage)?
What are the causes of acute kidney injury?
Which medical conditions can cause a burning sensation on the skin when exposed to sunlight?
What is the differential diagnosis for a bronchoalveolar lavage showing approximately 65% neutrophils, 23% monocytes, and 12% lymphocytes?
What is the appropriate co‑amoxiclav dose for a 5‑year‑old child weighing 19.2 kg?
What is the appropriate amoxicillin dose for a 4‑month‑old infant weighing 12 lb (≈5.4 kg) with otitis media, dosed at 80 mg per kilogram?
How should I evaluate and manage a patient who develops acute kidney injury after receiving zoledronic acid (Aclasta) infusion?
In a hospice patient with chronic obstructive pulmonary disease who has an oxygen saturation of 96% while breathing room air, why is this considered high and how can it be lowered?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.